Template:Dobutamine: Difference between revisions

Revision as of 15:10, 11 February 2014

Dobutamine
DOBUTamine^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Dobutamine
ClinicalTrials.gov

@@ Line 25: / Line 25: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Dobutamine nonclinical toxicology|Nonclinical Toxicology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Dobutamine clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Dobutamine how supplied storage and handling|How Supplied/Storage and Handling]]